Tag: Sanofi
Mylan, Biocon get FDA approval for Semglee in type 1 and 2 diabetes
Mylan and Biocon have secured approval from the US Food and Drug Administration (FDA) for Semglee (insulin glargine injection) in vial and pre-filled pen presentations ... Read More
Dupixent delivers positive results in eosinophilic esophagitis trial
Regeneron Pharmaceuticals and Sanofi said that their co-developed eczema drug Dupixent (dupilumab) has met the co-primary endpoints of Part A of a phase 3 trial ... Read More
Vaccine giants Sanofi, GSK announce COVID-19 vaccine partnership
French pharma company Sanofi has announced a COVID-19 vaccine partnership with GlaxoSmithKline (GSK) to develop an adjuvanted vaccine for the novel coranavirus, by combining their ... Read More
Baxter to acquire Seprafilm Adhesion Barrier from Sanofi for $350m
Baxter International, a US-based health care company, has signed a deal worth $350 million to acquire Seprafilm Adhesion Barrier and related assets from French pharma ... Read More
Sanofi, Regeneron secure Libtayo EMA approval for a type of skin cancer
Libtayo EMA approval : The European Commission has given conditional approval for Libtayo (cemiplimab) for the treatment of adult patients with metastatic or locally advanced ... Read More
Sanofi, Regeneron report Dupixent FDA approval for asthma
Dupixent FDA approval : Dupixent (dupilumab), an eczema drug the co-developed by Sanofi and Regeneron Pharmaceuticals, has been approved by the US Food and Drug Administration ... Read More
Sanofi announces $396m vaccine manufacturing facility in Toronto
French pharma company Sanofi has announced a new vaccine manufacturing facility in Toronto to be built with an investment of CAD500 million ($396.3 million) at ... Read More
Sanofi to acquire Belgian biotech company Ablynx for €3.9bn
Pharma acquisition news : French pharma company Sanofi has clinched a deal to acquire Belgian biotech company Ablynx for a sum of around €3.9 billion ... Read More
Sanofi Acquisition of Bioverativ : Sanofi to buy US biotech company for $11.6bn
Pharma acquisition news : French pharma company Sanofi has struck a deal to acquire Bioverativ, a US biotech company for about $11.6 billion to grow ... Read More
Sanofi to develop Principia Biopharma multiple sclerosis drug candidate
Pharma industry news : French pharma company Sanofi and Principia Biopharma, a California-based biotechnology company have reached a deal to develop the latter’s multiple sclerosis ... Read More